Valiant Laboratories Limited (VALIANTLAB.NS)

INR 93.79

(0.34%)

Operating Income Summary of Valiant Laboratories Limited

  • Valiant Laboratories Limited's latest annual operating income in 2023 was - INR , down -101.8% from previous year.
  • Valiant Laboratories Limited's latest quarterly operating income in 2024 Q1 was -29.23 Million INR , up 100.0% from previous quarter.
  • Valiant Laboratories Limited reported an annual operating income of 383.9 Million INR in 2022, down -8.32% from previous year.
  • Valiant Laboratories Limited reported an annual operating income of 418.74 Million INR in 2021, down -14.2% from previous year.
  • Valiant Laboratories Limited reported a quarterly operating income of 10.83 Million INR for 2023 Q2, down -81.32% from previous quarter.
  • Valiant Laboratories Limited reported a quarterly operating income of -6.91 Million INR for 2023 FY, down -101.8% from previous quarter.

Annual Operating Income Chart of Valiant Laboratories Limited (2023 - 2020)

Historical Annual Operating Income of Valiant Laboratories Limited (2023 - 2020)

Year Operating Income Operating Income Growth
2023 - INR -101.8%
2022 383.9 Million INR -8.32%
2021 418.74 Million INR -14.2%
2020 488.07 Million INR 0.0%

Peer Operating Income Comparison of Valiant Laboratories Limited

Name Operating Income Operating Income Difference
Alembic Pharmaceuticals Limited 5.75 Billion INR 100.0%
Hester Biosciences Limited 364.77 Million INR 100.0%
Aarti Drugs Limited 7.14 Billion INR 100.0%
Aarti Pharmalabs Limited 3.12 Billion INR 100.0%
Albert David Limited 1.33 Billion INR 100.0%
Alembic Limited 767.77 Million INR 100.0%
Alkem Laboratories Limited 19.46 Billion INR 100.0%
Bafna Pharmaceuticals Limited 237.66 Million INR 100.0%
Bajaj HealthCare Limited - INR NaN%
Biofil Chemicals and Pharmaceuticals Limited 20.65 Million INR 100.0%
Brooks Laboratories Limited -72.25 Million INR 100.0%
Eris Lifesciences Limited 5.18 Billion INR 100.0%
FDC Limited 3.03 Billion INR 100.0%
Glenmark Life Sciences Limited 8.97 Billion INR 100.0%
Gufic Biosciences Limited 2.89 Billion INR 100.0%
Hikal Limited 1.49 Billion INR 100.0%
Ind-Swift Limited 1.22 Billion INR 100.0%
Innova Captab Limited 2.53 Billion INR 100.0%
IOL Chemicals and Pharmaceuticals Limited 4.94 Billion INR 100.0%
Jagsonpal Pharmaceuticals Limited 214.04 Million INR 100.0%
Jubilant Pharmova Limited 5.18 Billion INR 100.0%
Lincoln Pharmaceuticals Limited 1.9 Billion INR 100.0%
Lupin Limited 27.75 Billion INR 100.0%
Mangalam Drugs & Organics Limited 27.45 Million INR 100.0%
Medico Remedies Limited 277.11 Million INR 100.0%
Morepen Laboratories Limited 4.17 Billion INR 100.0%
Nectar Lifesciences Limited 3.89 Billion INR 100.0%
Orchid Pharma Limited 2.36 Billion INR 100.0%
Procter & Gamble Health Limited 2.78 Billion INR 100.0%
RPG Life Sciences Limited 2.29 Billion INR 100.0%
Kilitch Drugs (India) Limited 208.05 Million INR 100.0%
Sigachi Industries Limited 1.47 Billion INR 100.0%
Solara Active Pharma Sciences Limited -3.85 Billion INR 100.0%
Suven Pharmaceuticals Limited 4.6 Billion INR 100.0%
Themis Medicare Limited 1.3 Billion INR 100.0%
Unichem Laboratories Limited - INR NaN%
Vaishali Pharma Limited 6.29 Million INR 100.0%
Wanbury Limited 1.7 Billion INR 100.0%
Windlas Biotech Limited 1.29 Billion INR 100.0%
ZIM Laboratories Limited 1.09 Billion INR 100.0%
Ind-Swift Laboratories Limited 2 Billion INR 100.0%
Ipca Laboratories Limited 29.59 Billion INR 100.0%
Sun Pharmaceutical Industries Limited 104.3 Billion INR 100.0%
Venus Remedies Limited 534.65 Million INR 100.0%
Sakar Healthcare Limited 495.5 Million INR 100.0%
Aurobindo Pharma Limited 104.5 Billion INR 100.0%
Divi's Laboratories Limited 18.31 Billion INR 100.0%
AstraZeneca Pharma India Limited 4.47 Billion INR 100.0%
Mankind Pharma Limited 40.86 Billion INR 100.0%
Sequent Scientific Limited - INR NaN%
Laurus Labs Limited 3.94 Billion INR 100.0%
Neuland Laboratories Limited 5.31 Billion INR 100.0%
J. B. Chemicals & Pharmaceuticals Limited 7.54 Billion INR 100.0%
Glenmark Pharmaceuticals Limited 6.5 Billion INR 100.0%
Zydus Lifesciences Limited 45.39 Billion INR 100.0%
Amrutanjan Health Care Limited 621.02 Million INR 100.0%
Wockhardt Limited 140 Million INR 100.0%
Bal Pharma Limited 214.56 Million INR 100.0%
Dr. Reddy's Laboratories Limited 67.72 Billion INR 100.0%
Bliss GVS Pharma Limited 1.23 Billion INR 100.0%
Par Drugs and Chemicals Limited 551.58 Million INR 100.0%
Caplin Point Laboratories Limited 7.22 Billion INR 100.0%
Shilpa Medicare Limited 3.76 Billion INR 100.0%
Ajanta Pharma Limited 19.67 Billion INR 100.0%
Aarey Drugs & Pharmaceuticals Limited 2.83 Million INR 100.0%
Granules India Limited 6.52 Billion INR 100.0%
Medicamen Biotech Limited - INR NaN%
Syncom Formulations (India) Limited 249.25 Million INR 100.0%
Piramal Enterprises Limited - INR NaN%
Torrent Pharmaceuticals Limited 25.33 Billion INR 100.0%
NATCO Pharma Limited 25.96 Billion INR 100.0%
Suven Life Sciences Limited -1.22 Billion INR 100.0%
Krebs Biochemicals & Industries Limited - INR NaN%
Strides Pharma Science Limited 5.22 Billion INR 100.0%
Indoco Remedies Limited 1.52 Billion INR 100.0%
Alpa Laboratories Limited 61.51 Million INR 100.0%
Lasa Supergenerics Limited -458 Million INR 100.0%
Sun Pharma Advanced Research Company Limited -4.11 Billion INR 100.0%